First quarter earnings season will be litmus test for sector
By Peter Winter
Monday, April 28, 2014
The first quarter earnings season kicked off last week with investors looking for strong financial results from the leading companies to stabilize the uncertainty that has surrounded the biotech sector these past few weeks.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.